PolyPid
PYPD
12 hedge funds and large institutions have $16.1M invested in PolyPid in 2020 Q2 according to their latest regulatory filings, with 12 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MCM
Moore Capital Management
New York
|
+$3.83M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
+$3.17M |
| 3 |
Millennium Management
New York
|
+$1.96M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$1.87M |
| 5 |
GTC
Ghost Tree Capital
New York
|
+$1.87M |
Top Sellers
PYPD Hedge Fund Activity: Q2 2020 in Review
12 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in PolyPid (PYPD) for Q2 2020, worth a combined $16.1M.
Buyers outnumbered sellers: 12 funds opened new PYPD positions and 0 closed out — a net gain of 12 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Moore Capital Management, opening a new position worth an estimated $3.83M.
- 12 institutional investors held PolyPid (PYPD) as of Q2 2020, up from 0 in Q1 2020.
- Funds reported $16.1M of PolyPid stock for Q2 2020.
- 12 funds opened new PolyPid positions in Q2 2020 and 0 closed out, a net change of +12 holders.
- The largest PolyPid buyer in Q2 2020 was Moore Capital Management, an estimated $3.83M added.
Based on aggregated 13F filings for Q2 2020.